↓ Skip to main content

Phase I trial of oral talactoferrin alfa in refractory solid tumors

Overview of attention for article published in Investigational New Drugs, September 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 500)
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
66 Dimensions

Readers on

mendeley
18 Mendeley
citeulike
1 CiteULike
Title
Phase I trial of oral talactoferrin alfa in refractory solid tumors
Published in
Investigational New Drugs, September 2005
DOI 10.1007/s10637-005-3690-6
Pubmed ID
Authors

Teresa G. Hayes, Gerald F. Falchook, Gauri R. Varadhachary, Dori P. Smith, Lisa D. Davis, Hari M. Dhingra, Benjamin P. Hayes, Atul Varadhachary

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 6%
Unknown 17 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 28%
Researcher 3 17%
Other 3 17%
Student > Ph. D. Student 3 17%
Lecturer > Senior Lecturer 1 6%
Other 3 17%
Readers by discipline Count As %
Medicine and Dentistry 8 44%
Agricultural and Biological Sciences 5 28%
Unspecified 3 17%
Biochemistry, Genetics and Molecular Biology 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2012.
All research outputs
#1,759,715
of 10,802,677 outputs
Outputs from Investigational New Drugs
#34
of 500 outputs
Outputs of similar age
#66,537
of 262,554 outputs
Outputs of similar age from Investigational New Drugs
#3
of 11 outputs
Altmetric has tracked 10,802,677 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 500 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,554 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.